Protease assay for therapeutic drug monitoring
US7320878B2 · kind B2 · utility
1Cited by
6References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 8, 2002 |
| Grant date | Jan 22, 2008 |
| Priority date | — |
| Expiry date | Nov 8, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/161
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention concerns a further development and use of biological assays to determine the amount or concentration of an active ingredient present in a sample. The enzyme assay of the present invention determines the amount or concentration of protease inhibitors, including retroviral protease inhibitors such as HIV inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.